Skip to content

BIONIK LABORATORIES CORP.

CIK 0001508381

← back to feed
Revenue (TTM)
$1.49M
+41.7% YoY FY Jun 2023
Net Income (TTM)
−$10.57M
+52.5% YoY FY Jun 2023
EPS Diluted (TTM)
−$1.70
+59.6% YoY FY Jun 2023
Gross Margin
58.4%
FY Jun 2023
Operating Margin
-689.6%
FY Jun 2023
Net Margin
-710.9%
FY Jun 2023
Free Cash Flow (TTM)
−$4.75M
FY Jun 2023
Cash
$427.38K
FY Jun 2023
Total Debt
$2.21M
FY Jun 2023
Shares Outstanding
12.48M sh
FY Jun 2023

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings